S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Better Than Oil Stocks (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
It's Called "the Singularity" (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
It's Called "the Singularity" (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Better Than Oil Stocks (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
It's Called "the Singularity" (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
It's Called "the Singularity" (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Better Than Oil Stocks (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
It's Called "the Singularity" (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
It's Called "the Singularity" (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Better Than Oil Stocks (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
It's Called "the Singularity" (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
It's Called "the Singularity" (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
NASDAQ:HSIC

Henry Schein (HSIC) Stock Price, News & Analysis

$79.86
+2.78 (+3.61%)
(As of 02/23/2024 08:53 PM ET)
Today's Range
$76.83
$81.21
50-Day Range
$72.58
$79.86
52-Week Range
$60.01
$85.75
Volume
3.24 million shs
Average Volume
1.06 million shs
Market Capitalization
$10.38 billion
P/E Ratio
23.77
Dividend Yield
N/A
Price Target
$79.25

Henry Schein MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.57 Rating Score
Upside/​Downside
0.8% Downside
$79.25 Price Target
Short Interest
Bearish
3.94% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.42
Upright™ Environmental Score
News Sentiment
0.95mentions of Henry Schein in the last 14 days
Based on 17 Articles This Week
Insider Trading
Selling Shares
$1.88 M Sold Last Quarter
Proj. Earnings Growth
11.84%
From $4.56 to $5.10 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.60 out of 5 stars

Medical Sector

271st out of 936 stocks

Medical & Hospital Equipment Industry

2nd out of 3 stocks


HSIC stock logo

About Henry Schein Stock (NASDAQ:HSIC)

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

HSIC Stock Price History

HSIC Stock News Headlines

Henry Schein (NASDAQ:HSIC) Stock Price Up 4.8%
The perfect AI stock under $10
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. This #1 AI company is at the forefront of it all.
The perfect AI stock under $10
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. This #1 AI company is at the forefront of it all.
Henry Schein (HSIC) Set to Announce Quarterly Earnings on Tuesday
HSIC Mar 2024 80.000 call
Henry Schein (HSIC) Set to Post Q4 Earnings: What Awaits?
Henry Schein Inc.
Henry Schein price target raised by $5 at Stifel, here's why
HSIC Henry Schein, Inc.
Q4 2018 Henry Schein Inc Earnings Call Transcript
Q1 2019 Henry Schein Inc Earnings Call Transcript
Q2 2019 Henry Schein Inc Earnings Call Transcript
Q3 2019 Henry Schein Inc Earnings Call Transcript
See More Headlines
Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2023
Today
2/25/2024
Next Earnings (Confirmed)
2/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical & hospital equipment
Sub-Industry
Health Care Distributors
Current Symbol
NASDAQ:HSIC
CUSIP
80640710
Employees
22,000
Year Founded
1932

Price Target and Rating

Average Stock Price Target
$79.25
High Stock Price Target
$96.00
Low Stock Price Target
$65.00
Potential Upside/Downside
-0.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
7 Analysts

Profitability

Net Income
$538 million
Pretax Margin
4.66%

Debt

Sales & Book Value

Annual Sales
$12.65 billion
Cash Flow
$6.46 per share
Book Value
$30.21 per share

Miscellaneous

Free Float
128,457,000
Market Cap
$10.38 billion
Optionable
Optionable
Beta
0.87

Social Links

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report














HSIC Stock Analysis - Frequently Asked Questions

Should I buy or sell Henry Schein stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HSIC shares.
View HSIC analyst ratings
or view top-rated stocks.

What is Henry Schein's stock price target for 2024?

7 brokerages have issued 1 year price objectives for Henry Schein's shares. Their HSIC share price targets range from $65.00 to $96.00. On average, they expect the company's share price to reach $79.25 in the next twelve months. This suggests that the stock has a possible downside of 0.8%.
View analysts price targets for HSIC
or view top-rated stocks among Wall Street analysts.

How have HSIC shares performed in 2024?

Henry Schein's stock was trading at $75.71 at the beginning of 2024. Since then, HSIC shares have increased by 5.5% and is now trading at $79.86.
View the best growth stocks for 2024 here
.

Are investors shorting Henry Schein?

Henry Schein saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 5,060,000 shares, an increase of 26.2% from the January 15th total of 4,010,000 shares. Based on an average daily volume of 1,140,000 shares, the days-to-cover ratio is presently 4.4 days. Currently, 3.9% of the shares of the company are sold short.
View Henry Schein's Short Interest
.

When is Henry Schein's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our HSIC earnings forecast
.

How can I listen to Henry Schein's earnings call?

Henry Schein will be holding an earnings conference call on Tuesday, February 27th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) released its quarterly earnings data on Monday, November, 13th. The company reported $1.32 EPS for the quarter, hitting the consensus estimate of $1.32. The firm earned $3.16 billion during the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a net margin of 3.51% and a trailing twelve-month return on equity of 16.08%. The business's revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.15 EPS.
Read the conference call transcript
.

When did Henry Schein's stock split?

Shares of Henry Schein split on the morning of Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were issued to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein announced that its board has authorized a share repurchase program on Thursday, August 18th 2022, which allows the company to buyback $400,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to repurchase up to 4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein issued an update on its FY 2023 earnings guidance on Monday, December, 11th. The company provided EPS guidance of 4.430-4.710 for the period, compared to the consensus EPS estimate of 5.270. The company issued revenue guidance of $12.3 billion-$12.5 billion, compared to the consensus revenue estimate of $12.9 billion.

What is Stanley M. Bergman's approval rating as Henry Schein's CEO?

451 employees have rated Henry Schein Chief Executive Officer Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among the company's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.68%), Generation Investment Management LLP (9.21%), Perpetual Ltd (2.44%), Boston Partners (2.03%), Fiduciary Management Inc. WI (1.76%) and Burgundy Asset Management Ltd. (1.26%). Insiders that own company stock include Bradford C Connett, David B Brous Jr, Gerald A Benjamin, James P Breslawski, James P Breslawski, Kurt P Kuehn, Lorelei Mcglynn, Mark E Mlotek, Michael S Ettinger, Philip A Laskawy, Scott Philip Serota, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends
.

How do I buy shares of Henry Schein?

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Henry Schein have any subsidiaries?
The following companies are subsidiares of Henry Schein: ACE Surgical Supply Co. Inc., ADS Florida, AUV Veterinary Services, Accord, Alpha Scientific, Arcade Dentaire, Arseus, Arseus Dental Solutions, Arseus Lab, Becker-Parkin Dental Supply, BioHorizons Inc., Butler Schein Animal Health, C&M Vetlink, Camlog USA Inc., DNA Anthos Impianti, Dental Cremer, Dental Trey, Elite Computer Italia, Exan Enterprises Inc., HS Brand Management LLC, HS TM Holdings LLC, HSFR Inc., Handpiece Parts & Repairs Inc., Henry Schein Europe Inc., Henry Schein Global Sourcing Inc., Henry Schein Latin America Pacific Rim Inc., Henry Schein Medical Systems Inc., Henry Schein Practice Solutions Inc., InSource Inc., Jorgen Kruuse, Lincoln Dental Supply, Logiciel Julie, Maddox Practice Group, Maravet, Marrodent, Medivet, Medka, Minerva Dental Limited, Modern Laboratory Services, NLS Animal Health, Noviko, Ortho Organizers, Ortho Technology, Prism Medical Products L.L.C., Prism Medical Products LLC, Project Helium Holdings LLC, Project Spartan Holdings Corp., RxWorks, SG Healthcare Corp., Sirona Direct, SmartPak Equine LLC, Software of Excellence, Sogim Grimouille, Southern Anesthesia & Surgical, S & S Discount Inc., TDSC Inc., The Exan Group, Veterinary Instrumentation, Vetstreet, W. & J. Dunlop, eAssist Inc., and scil animal care.
Read More
This page (NASDAQ:HSIC) was last updated on 2/26/2024 by MarketBeat.com Staff